SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-100593
Filing Date
2016-05-11
Accepted
2016-05-10 19:46:06
Documents
52
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v439072_10q.htm 10-Q 283548
2 EXHIBIT 31.1 v439072_ex31-1.htm EX-31.1 8917
3 EXHIBIT 32.1 v439072_ex32-1.htm EX-32.1 4204
  Complete submission text file 0001144204-16-100593.txt   2852275

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT nwbo-20160331.xml EX-101.INS 497172
5 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20160331.xsd EX-101.SCH 38412
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20160331_cal.xml EX-101.CAL 33455
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20160331_def.xml EX-101.DEF 241216
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20160331_lab.xml EX-101.LAB 270581
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20160331_pre.xml EX-101.PRE 261714
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 161637419
SIC: 2834 Pharmaceutical Preparations